Pivoting Toward Impact

Stanford School of Medicine

Neuroscientist David Eagleman discusses his pivot from academic researcher to entrepreneur and how it was fueled by a desire to create a positive and practical impact. Eagleman, who teaches part time at Stanford University, contrasts the conservative approach that public agencies take when funding scientific research, versus the fervor venture capitalists feel for “the big, leapy questions.”